- Spectranetics (NASDAQ:SPNC +5.8%) Q2 results: Revenue: $43.6M (+10.4%); COGS: $10.5M (-0.9%); Gross Profit: $33.0M (+14.6%); R&D Expense: $5.7M (+3.6%); SG&A Expense: $28.5M (+23.4%); Operating Income/Loss: ($5.8M) (-728.6%); Net Loss: $6.6M (-842,9%); EPS: ($0.16) (-700.0%); Quick Assets: $107.0M (-16.7%).
- 2014 Guidance: Revenue: $198.5M - 201.0M; ex. AngioScore revenue: $171.5M - 174.0M; net loss per share: ($0.85 - 0.90).
Spectranetics updates guidance after Q2 results
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SPNC | - | - |
The Spectranetics Corporation |